Potential for a Plant-Made SARS-CoV-2 Neutralizing Monoclonal Antibody as a Synergetic Cocktail Component

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a public health crisis over the last two years. Monoclonal antibody (mAb)-based therapeutics against the spike (S) protein have been shown to be effective treatments for SARS-CoV-2 infection, especially the original viral strain...

Descripción completa

Detalles Bibliográficos
Autores principales: Jugler, Collin, Sun, Haiyan, Grill, Francisca, Kibler, Karen, Esqueda, Adrian, Lai, Huafang, Li, Yize, Lake, Douglas, Chen, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145534/
https://www.ncbi.nlm.nih.gov/pubmed/35632528
http://dx.doi.org/10.3390/vaccines10050772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145534/
https://www.ncbi.nlm.nih.gov/pubmed/35632528
http://dx.doi.org/10.3390/vaccines10050772

Ejemplares similares